Skip to main content

Table 2 Associations between proportion of pregnancy under the protection of IRS and outcomes measured at birth

From: Reductions in malaria in pregnancy and adverse birth outcomes following indoor residual spraying of insecticide in Uganda

Outcome

Proportion of pregnancy under the protection of IRS

None

>0–20 %

>20–43 %

Placental blood positive for malaria parasites by LAMPa

 Risk

22/131 (16.8 %)

1/88 (1.1 %)

1/61 (1.6 %)

 aORb (95 % CI)

Reference group

0.03 (0–0.25)

0.05 (0.01–0.41)

 P value

0.001

0.006

Any evidence of placental malaria by histopathologya

 Risk

63/132 (47.7 %)

25/88 (28.4 %)

17/62 (27.4 %)

 aORb (95 % CI)

Reference group

0.77 (0.35–1.69)

0.63 (0.27–1.48)

 P value

0.51

0.29

Moderate-high grade pigment deposition by histopathologya

 Risk

37/132 (28.0 %)

11/88 (12.5 %)

9/62 (14.5 %)

 aORb (95 % CI)

Reference group

0.52 (0.20–1.36)

0.54 (0.20–1.47)

 P value

0.18

0.23

 Risk

28/134 (20.9 %)

9/90 (10.0 %)

2/65 (3.1 %)

LBW (<2500 g)

 aORb (95 % CI)

Reference group

0.29 (0.12–0.75)

0.08 (0.02–0.39)

 P value

0.01

0.002

 Risk

23/134 (17.2 %)

3/90 (3.3 %)

1/65 (1.5 %)

Pre-term delivery (<37 weeks)

 aORb (95 % CI)

Reference group

0.13 (0.03–0.53)

0.05 (0.01–0.43)

 P value

0.005

0.006

Fetal/neonatal deaths

 Risk

10/134 (7.5 %)

1/90 (1.1 %)

0/65 (0 %)

 aORb (95 % CI)

Reference group

0.10 (0–0.86)

0 (n/a)

 P value

0.03

0.03

  1. LBW low birth weight; aOR adjusted odds ratio
  2. aIncludes all subjects with evaluable outcomes of interest
  3. bOdds ratio adjusted for gravidity, household wealth, presence of parasites at enrollment, gestational age study drugs started, and assigned IPTp treatment arm